Glucose Mini-Plasco B. Braun (Glucose Monohydrate)

Glucose Mini-Plasco B. Braun is indicated for several clinical situations where rapid provision of carbohydrate calories and fluid balance are required.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
• Fluid and electrolyte replacement in perioperative or critical‑care settings.
• Support of energy metabolism during prolonged fasting or surgical procedures.
• Dilution medium for compatible intravenous medications, when appropriate.

When administered intravenously, Glucose Mini-Plasco B. Braun may be associated with a range of observed effects, most of which are related to its glucose content and osmolarity.

Common

• Transient rise in blood glucose levels.
• Mild hyperosmolarity leading to temporary thirst or mild nausea.
• Local irritation at the infusion site, such as erythema or discomfort.
• Electrolyte shifts, most commonly mild potassium changes.

Serious

• Severe hyperglycemia, especially in patients with diabetes mellitus.
• Fluid overload resulting in pulmonary edema or congestive heart failure.
• Hyperosmolar hyperglycemic state (HHS) in susceptible individuals.

Clinicians should observe several precautions before and during the use of Glucose Mini-Plasco B. Braun to minimize risks and ensure appropriate therapy.

• Verify patient’s blood glucose and adjust infusion rate in diabetics or those prone to hyperglycemia.
• Assess fluid status and cardiac function to avoid volume overload.
• Use aseptic technique to prevent catheter‑related infections.
• Monitor serum electrolytes, particularly potassium and sodium, during prolonged administration.
• Avoid rapid infusion in neonates or patients with compromised vascular integrity.
• Consider compatibility with other IV drugs; incompatibility may cause precipitation.

Glucose Mini-Plasco B. Braun can interact with other medications or clinical conditions; awareness of these interactions helps maintain safety.

Avoid

• Avoid concurrent administration with high‑dose insulin infusions without close glucose monitoring.
• Avoid mixing with calcium‑containing solutions that may precipitate.
• Avoid use in patients with uncontrolled diabetes mellitus when alternative carbohydrate sources are available.

Use with caution

• Use with caution when combined with diuretics, as fluid shifts may be amplified.
• Use with caution in renal impairment; monitor electrolyte balance closely.
• Use with caution alongside beta‑blockers, which can mask hypoglycemia symptoms.